.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Harvard Business School
Teva
Fuji
McKesson
Julphar
Chubb
Queensland Health
Moodys
Mallinckrodt

Generated: September 26, 2017

DrugPatentWatch Database Preview

Mylan Ireland Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for MYLAN IRELAND LTD, and what generic and branded alternatives to MYLAN IRELAND LTD drugs are available?

MYLAN IRELAND LTD has eight approved drugs.



Summary for Applicant: Mylan Ireland Ltd

Patents:0
Tradenames:6
Ingredients:6
NDAs:8
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Ireland Ltd
PIROXICAM
piroxicam
CAPSULE;ORAL074118-001Jun 15, 1993ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Ireland Ltd
THEOPHYLLINE
theophylline
TABLET, EXTENDED RELEASE;ORAL040560-002Apr 21, 2006ABRXNoYes► Subscribe► Subscribe► Subscribe
Mylan Ireland Ltd
ARIXTRA
fondaparinux sodium
INJECTABLE;SUBCUTANEOUS021345-004May 28, 2004APRXYesYes► Subscribe► Subscribe► Subscribe
Mylan Ireland Ltd
PIROXICAM
piroxicam
CAPSULE;ORAL074116-001Jun 15, 1993ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Ireland Ltd
MIACALCIN
calcitonin salmon
INJECTABLE;INJECTION017808-001Jul 3, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan Ireland Ltd
ARIXTRA
fondaparinux sodium
INJECTABLE;SUBCUTANEOUS021345-003May 28, 2004APRXYesYes► Subscribe► Subscribe► Subscribe
Mylan Ireland Ltd
CARBAMAZEPINE
carbamazepine
CAPSULE, EXTENDED RELEASE;ORAL076697-001May 20, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Ireland Ltd
CARBAMAZEPINE
carbamazepine
CAPSULE, EXTENDED RELEASE;ORAL076697-002May 20, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Ireland Ltd
MIACALCIN
calcitonin salmon
SPRAY, METERED;NASAL020313-002Aug 17, 1995DISCNYesNo► Subscribe► Subscribe► Subscribe
Mylan Ireland Ltd
ARIXTRA
fondaparinux sodium
INJECTABLE;SUBCUTANEOUS021345-001Dec 7, 2001APRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Mylan Ireland Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Ireland Ltd
MIACALCIN
calcitonin salmon
SPRAY, METERED;NASAL020313-002Aug 17, 1995► Subscribe► Subscribe
Mylan Ireland Ltd
ARIXTRA
fondaparinux sodium
INJECTABLE;SUBCUTANEOUS021345-001Dec 7, 2001► Subscribe► Subscribe
Mylan Ireland Ltd
MIACALCIN
calcitonin salmon
SPRAY, METERED;NASAL020313-002Aug 17, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Cipla
Fuji
Baxter
Novartis
Julphar
Farmers Insurance
McKinsey
UBS
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot